Free Trial
OTCMKTS:RDGL

Vivos (RDGL) Stock Price, News & Analysis

Vivos logo
$0.13 +0.01 (+4.31%)
As of 05/23/2025 03:52 PM Eastern

About Vivos Stock (OTCMKTS:RDGL)

Key Stats

Today's Range
$0.12
$0.14
50-Day Range
$0.10
$0.15
52-Week Range
$0.06
$0.26
Volume
493,054 shs
Average Volume
954,414 shs
Market Capitalization
$60.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

Receive RDGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vivos and its competitors with MarketBeat's FREE daily newsletter.

RDGL Stock News Headlines

Vivos Inc.
$19 for a FULL YEAR of stock picks?!
Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.
See More Headlines

RDGL Stock Analysis - Frequently Asked Questions

Vivos' stock was trading at $0.1149 on January 1st, 2025. Since then, RDGL shares have increased by 15.8% and is now trading at $0.1330.
View the best growth stocks for 2025 here
.

Shares of RDGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vivos investors own include MannKind (MNKD), Agenus (AGEN), APA (APA), Aphria (APHA), Bionano Genomics (BNGO), Churchill Capital Corp IV (CCIV) and Canopy Growth (CGC).

Company Calendar

Today
5/24/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Finance
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:RDGL
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-2,890,000.00
Pretax Margin
-12,345.83%

Debt

Sales & Book Value

Annual Sales
$20,000.00
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
-6.65

Miscellaneous

Free Float
369,805,000
Market Cap
$60.32 million
Optionable
Not Optionable
Beta
1.10
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:RDGL) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners